Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer

Gene Signatures for the Prediction of Response to Bacillus Calmette-Guerin Immunotherapy in Primary pT1 Bladder Cancers

(2010) Y. J. Kim et al.   CLINICAL CANCER RESEARCH

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

(2010) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: Randomized controlled trial by the BCG Tokyo Strain Study Group

(2010) Hirofumi Koga et al.   INTERNATIONAL JOURNAL OF UROLOGY

Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors

(2010) Ju-Seog Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

(2009) Per-Uno Malmström et al.   EUROPEAN UROLOGY

The Role of Bacillus Calmette-Guérin in the Treatment of Non–Muscle-Invasive Bladder Cancer

(2009) Paolo Gontero et al.   EUROPEAN UROLOGY

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

(2009) Richard J. Sylvester et al.   EUROPEAN UROLOGY

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association

(2009) Eiji Kikuchi et al.   INTERNATIONAL JOURNAL OF UROLOGY

Clinical outcome of high-grade non-muscle-invasive bladder cancer: A long-term single center experience

(2009) Shoichi Iida et al.   INTERNATIONAL JOURNAL OF UROLOGY

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

(2009) Jesus Fernandez-Gomez et al.   JOURNAL OF UROLOGY

Is Maintenance Bacillus Calmette-Guérin Really Necessary?

(2008) Harry W. Herr   EUROPEAN UROLOGY

EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

(2008) Marko Babjuk et al.   EUROPEAN UROLOGY

Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy–Associated Adverse Events

(2008) J. Alfred Witjes et al.   EUROPEAN UROLOGY SUPPLEMENTS

Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

(2007) Jesus Fernandez-Gomez et al.   EUROPEAN UROLOGY

History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story

(2007) Harry W. Herr et al.   JOURNAL OF UROLOGY

Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guérin therapy

(2007) Jared G. Heiner et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS